These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Why I believe nanoparticles are crucial as a carrier for targeted drug delivery. Baker JR Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2013; 5(5):423-9. PubMed ID: 23633301 [TBL] [Abstract][Full Text] [Related]
4. Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles. Liu Y; Miyoshi H; Nakamura M Int J Cancer; 2007 Jun; 120(12):2527-37. PubMed ID: 17390371 [TBL] [Abstract][Full Text] [Related]
5. Nanomedicine opportunities for cardiovascular disease with perfluorocarbon nanoparticles. Lanza GM; Winter PM; Caruthers SD; Hughes MS; Cyrus T; Marsh JN; Neubauer AM; Partlow KC; Wickline SA Nanomedicine (Lond); 2006 Oct; 1(3):321-9. PubMed ID: 17716162 [TBL] [Abstract][Full Text] [Related]
6. Inorganic hollow nanoparticles and nanotubes in nanomedicine Part 1. Drug/gene delivery applications. Son SJ; Bai X; Lee SB Drug Discov Today; 2007 Aug; 12(15-16):650-6. PubMed ID: 17706547 [TBL] [Abstract][Full Text] [Related]
7. Ocular drug delivery: nanomedicine applications. Vandervoort J; Ludwig A Nanomedicine (Lond); 2007 Feb; 2(1):11-21. PubMed ID: 17716187 [TBL] [Abstract][Full Text] [Related]
8. Role of nanotechnology in developing new therapies for diseases of the nervous system. Jain KK Nanomedicine (Lond); 2006 Jun; 1(1):9-12. PubMed ID: 17716203 [No Abstract] [Full Text] [Related]
9. Nanomedicine: a matter of rhetoric? Nat Mater; 2006 Apr; 5(4):243. PubMed ID: 16582920 [No Abstract] [Full Text] [Related]
10. New-concept chemotherapy by nanoparticles of biodegradable polymers: where are we now? Feng SS Nanomedicine (Lond); 2006 Oct; 1(3):297-309. PubMed ID: 17716160 [TBL] [Abstract][Full Text] [Related]
11. Nanomedicine for the prevention, treatment and imaging of atherosclerosis. Psarros C; Lee R; Margaritis M; Antoniades C Nanomedicine; 2012 Sep; 8 Suppl 1():S59-68. PubMed ID: 22640906 [TBL] [Abstract][Full Text] [Related]
12. Liposomal drug delivery systems: from concept to clinical applications. Allen TM; Cullis PR Adv Drug Deliv Rev; 2013 Jan; 65(1):36-48. PubMed ID: 23036225 [TBL] [Abstract][Full Text] [Related]
13. Nanohazards: knowledge is our first defence. Barnard AS Nat Mater; 2006 Apr; 5(4):245-8. PubMed ID: 16582921 [No Abstract] [Full Text] [Related]
14. Chitosan nanoparticles for oral drug and gene delivery. Bowman K; Leong KW Int J Nanomedicine; 2006; 1(2):117-28. PubMed ID: 17722528 [TBL] [Abstract][Full Text] [Related]
15. Multifunctional nanoparticles--properties and prospects for their use in human medicine. Sanvicens N; Marco MP Trends Biotechnol; 2008 Aug; 26(8):425-33. PubMed ID: 18514941 [TBL] [Abstract][Full Text] [Related]
16. Liposomes and other vesicular systems: structural characteristics, methods of preparation, and use in nanomedicine. Elizondo E; Moreno E; Cabrera I; Córdoba A; Sala S; Veciana J; Ventosa N Prog Mol Biol Transl Sci; 2011; 104():1-52. PubMed ID: 22093216 [TBL] [Abstract][Full Text] [Related]
17. Inorganic hollow nanoparticles and nanotubes in nanomedicine Part 2: Imaging, diagnostic, and therapeutic applications. Son SJ; Bai X; Lee SB Drug Discov Today; 2007 Aug; 12(15-16):657-63. PubMed ID: 17706548 [TBL] [Abstract][Full Text] [Related]
18. PharmaMedDevice 2007. Issues in nanodrug delivery and personalized medicine. Bawa R IDrugs; 2007 Jul; 10(7):455-8. PubMed ID: 17642014 [No Abstract] [Full Text] [Related]
19. Micro- and nanoparticles--medical applications. Jătariu A; Peptu C; Popa M; Indrei A Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):1160-9. PubMed ID: 20191893 [TBL] [Abstract][Full Text] [Related]
20. Interview with Vladimir P Torchilin: liposomal carriers for drug delivery. Torchilin VP Ther Deliv; 2013 May; 4(5):537-8. PubMed ID: 23647271 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]